CN1150025C - Baoling tea for preventing and treating thrombosis and its preparing process - Google Patents

Baoling tea for preventing and treating thrombosis and its preparing process Download PDF

Info

Publication number
CN1150025C
CN1150025C CNB011267186A CN01126718A CN1150025C CN 1150025 C CN1150025 C CN 1150025C CN B011267186 A CNB011267186 A CN B011267186A CN 01126718 A CN01126718 A CN 01126718A CN 1150025 C CN1150025 C CN 1150025C
Authority
CN
China
Prior art keywords
tea
radix
chinese medicine
medicine composition
baoling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011267186A
Other languages
Chinese (zh)
Other versions
CN1338283A (en
Inventor
季友林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011267186A priority Critical patent/CN1150025C/en
Publication of CN1338283A publication Critical patent/CN1338283A/en
Application granted granted Critical
Publication of CN1150025C publication Critical patent/CN1150025C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to Baoling tea for preventing and treating thrombotic diseases and a preparing process thereof. The Baoling tea is a combination of Chinese herbal medicines in a mode of tea diet therapy and is characterized in that the Baoling tea comprises 0.05 to 0.1g of radix glycyrrhiza, 0.05 to 0.1g of wild chrysanthemum, 1 to 2g of barley, 2 to 4g of red sage root, 1 to 2g of Gynostemma pentaphylla, 0.5 to 1.5g of ginkgo leaf, 0.1 to 0.5g of rhubarb and 0.2 to 0.8g of hawthorn fruit; 6g of the Chinese herbal medicines is packaged into one bag. The Chinese herbal medicines are pulverized into powder with 40 to 80 meshes. The Baoling can prevent and treat thrombotic diseases and relatively relieve hypertension, hyperlipemia and hyperglycemia along with thrombotic diseases. The Baoling tea changes traditional customs of medicine administration, body building and nourishment while in diseases in a mode of tea diet therapy, the combination of thrombus prediction and the tea diet therapy of the Baoling tea can control and relieve the state of diseases and realize the health of constitution and longevity. The price of Baoling tea is 1/10 of that of a common medicine and is 1/20 to 1/50 of that of an import medicine, and thus, the Baoling tea is accepted by common people. Practice and investigation at certain places show that the present invention provides a piece of good news for human health.

Description

A kind of have Chinese medicine composition of controlling the thrombotic disease effect in advance and preparation method thereof
Technical field:
The present invention relates to a kind of health product, particularly disclose a kind of Chinese medicine composition of controlling the thrombotic disease effect in advance and preparation method thereof that has for human life lengthening.
Background technology:
Many cooking cultures are arranged on the human history, a large amount of tea culture is also arranged, China is the big country that produces tea, tea export also is the first in the world, therefore simple Folium Camelliae sinensis or tea product are of long standing and well established, and the Folium Camelliae sinensis tea-drinking has many advantages, but inevitable defective is also arranged.Drink strong tea for a long time in a large number according to scientific research and can cause atherosclerosis.Then there is more defects in the tea product of popular coffee and so on.Along with enriching of social material conditions, the people that suffer from hypertension, hyperlipidemia, hyperglycemia and thrombotic disease are increasing, no matter thrombotic disease has all become human mortality and first reason disabling at China or western developed country, and annual about 1,300 ten thousand people die from this disease.People suffer from such disease and seek medical advice often and take medicine, medicine commonly used is: medicines such as aspirin, persantin, Radix Salviae Miltiorrhizae, be used for clinical treatment and then use medicines such as urotoxin always, the Drug therapy disease, then poison is paid effect greatly often, price is expensive, curative effect is little, and the U.S. also can only reduce in 5% the sickness rate of thrombotic disease, the control of mortality rate according to statistics, and China is about 3%.
Summary of the invention:
Technical problem to be solved by this invention can make the sickness rate of people's thrombotic disease, mortality rate reduce greatly, reach more than 60%,, effectively prevent the burst and the recurrence of heart and brain thrombotic disease for the China and the people of the world's health has contribution, break away from the puzzlement of thrombotic disease, allow more old people's life lengthening.
Technical scheme of the present invention is with tea-drinking dietetic therapy mode, the Chinese herbal medicine of tea culture and motherland is combined, be a kind of Chinese medicine composition of controlling the thrombotic disease effect in advance that has, it is a kind of Chinese medicine composition in tea-drinking dietetic therapy mode, it is characterized in that the compound recipe of this Chinese medicine composition and proportioning are as follows:
Radix Glycyrrhizae 0.05~0.1g
Flos Chrysanthemi Indici 0.05~0.1g
Fructus Hordei Vulgaris 0.1~0.3g
The Radix Astragali 1~2g
Radix Salviae Miltiorrhizae 2~4g
Herb Gynostemmae Pentaphylli 1~2g
Folium Ginkgo 0.5~1.5g
Radix Et Rhizoma Rhei 0.1~0.5g
Fructus Crataegi 0.2~0.8g.
Can know by above-mentioned compound recipe, the present invention selects the said herbal medicine kind, it is the most common Chinese herbal medicine of motherland, inexpensively accepted by the numerous common people, there is not toxic and side effects in the compound recipe, Folium Ginkgo is because its haemolysis function is very big, and adopted it, few toxic and side effects arranged but take all the year round human body is not enough to produce malicious secondary effect.The present invention adopts the Radix Astragali simply, and it to erythrocytic reparation, to the hardened improvement of erythrocyte detailed outline, has tangible effect to the protection of erythrocyte deformability.In addition based on natural, do not add any additives, there is the present invention to adopt tea product mode again, keep its Chinese living habit most effectively, therefore will after pulverizing, carry out fractional pack again after the compound recipe proportioning, the present invention upgrades on theory, and people are healthy longevity, tackles the affluenza of characteristics of the times, not to adopt to take medicine to seek medical advice, neither adopt Zi Fill nutrition to come body-building, but adopt the way of tea-drinking, a kind of change of life style, therefore be called " dietetic therapy of tea product " method, really, according to compound recipe of the present invention, the Chinese medicine that proportioning is made, the good result of its prevention heart and brain thrombotic disease is identical.The present invention also has special method in the selection of compound recipe with making, and further sets forth by the following examples.
The specific embodiment:
Embodiment 1 technical scheme according to the present invention prepares a kind of Chinese medicine composition of controlling the thrombotic disease effect in advance that has, and it is characterized in that the compound recipe of this Chinese medicine composition and proportioning elect as:
Radix Glycyrrhizae 0.05g
Flos Chrysanthemi Indici 0.05g
Fructus Hordei Vulgaris 0.1g
Radix Astragali 2.5g
Radix Salviae Miltiorrhizae 2g
Herb Gynostemmae Pentaphylli 1g
Folium Ginkgo 0.5g
Radix Et Rhizoma Rhei 0.1g
Fructus Crataegi 0.2g.
Selection to above-mentioned compound recipe will be noted the place of production, meticulous selection, can not be an incompetent person or a person unequal to his task, as the Radix Astragali simply, can only selected " Radix Astragali ", be as the criterion with Heilungkiang, the sweet peaceful Radix Astragali in Shan, in compound recipe is made, note scientific and reasonable, making as the Radix Astragali, need carry out " processed with honey " technology, obtain Radix Astragali (processed with Mel), Chinese herbal medicine all need carry out selection, cleaning, exsiccant process to respectively distinguishing the flavor of in the compound recipe, carry out compatibility and pulverizing then, pulverize the back fineness and be controlled at 40~80 orders, carry out the packing envelope again, envelope should have moistureproof performance.
Embodiment 2 has Chinese medicine composition compound recipe and the proportioning of controlling the thrombotic disease effect in advance to elect as:
Radix Glycyrrhizae 0.1g
Flos Chrysanthemi Indici 0.1g
Fructus Hordei Vulgaris 0.2g
Radix Astragali 2g
Radix Salviae Miltiorrhizae 1.3g
Herb Gynostemmae Pentaphylli 1.4g
Folium Ginkgo 0.8g
Radix Et Rhizoma Rhei 0.3g
Fructus Crataegi 0.3g.
Embodiment 3, have Chinese medicine composition compound recipe and the proportioning of controlling the thrombotic disease effect in advance to elect as:
Radix Glycyrrhizae 0.1g
Flos Chrysanthemi Indici 0.1g
Fructus Hordei Vulgaris 0.1g
Radix Astragali 3g
Radix Salviae Miltiorrhizae 1g
Herb Gynostemmae Pentaphylli 1g
Folium Ginkgo 1g
Radix Et Rhizoma Rhei 0.1g
Fructus Crataegi 0.1g.
The tangible beneficial effect of the present invention: 1) the little bitterness temperature of Chinese herbal medicine in the compound recipe, blood vessels are circulated, blood circulation promoting and blood stasis dispelling has extremely good effect, take the energy life lengthening for a long time, because selection and the characteristics of making, make effect more obvious, compare, can play better health-care effect with common tea culture now.2) prophylactic purpose of Ancient Times in China medical science is very clear and definite: " on cure not treating the disease affected, and preventive treatment of disease ".The present invention can control thrombotic disease in advance, as atherosclerosis, controlling in advance of diseases such as myocardial infarction, ischemic cerebral apoplexy are dead, the diabetic complication behind the cerebral thrombosis thromboembolism, thrombosis, kidney disease complication, disseminated inravascular coagulation, to reach effective aim, and these diseases are not in case control outbreak, to people's life is very big harm, affects that people normally learn, live and work.3) Chinese medicine composition of the present invention adopts " dietetic therapy of tea product " method, and prolonged application reaches disease controls purpose in advance, reaches good health and a long life.And economically owing to adopt cheap Chinese herb compound, the Chinese medicine composition expense only is 1/10 of health product commonly used now or a common drug valency, is 1/20~1/50 of imported medicine valency, and very easy to use.
The present invention has experienced a period of time practice, the application situation is investigated, in the river, Zhejiang, Hu Er province one city carries out the extensive social practice of triennium, adopts the thrombosis forecast method, carrying out thrombosis controls in advance, in the nearly 10000 people group, carry out heart and brain thrombosis health care research, reached good effect, adopt tea-drinking to carry out the tea-drinking dietetic therapy, to controlling this human pertinacious disease of thrombotic disease in advance, can make health longevity, obtain patient's welcome, society certainly.Here for two examples in order to the explanation:
Zhu * * sir, Yang Zhou city retired veteran cadre, man 79 years old, live Shao Zhai residential district, pinnacle road, Yang Zhou city 10/102, suffered from cerebral thrombosis in 97 years, after the exercise of taking medicine for a long time, but have little effect the frequent numbness of hand of readme, giddy, thrombosis prediction on April 20th, 2000 Q=60, drink product of the present invention then continuously, check on May 20 thrombosis Q=40, check on July 1 Q=17, check on August 6 Q=14, Mr. Zhu adheres to the tea-drinking dietetic therapy of product of the present invention and adheres to thrombosis prediction, and health is fine always, and other said him young 20 years.Mr. Zhu says: " I drop to Q=14 human body normal value from thrombosis index Q=60, rely on your invention to realize the Chinese herbal medicine really something of motherland.”
The another one journey * *, man 62 years old, family is also at Yang Zhou; A common retired worker, he said it to anyone he came across, and he has suffered from cerebral thrombosis, in despair, holding up and removing to predict thrombosis by the household, and clothes drink product of the present invention, can recover after one month on foot, again can be by bike after two months, very healthy now, as normal healthy people.Above-mentioned two examples all are the data on " river, Zhejiang, the thrombus prevention actual measurement of area, Shanghai are introduced ", all are out and out effects, this shows that the present invention will bring a Gospel to human health.

Claims (6)

1, a kind of have a Chinese medicine composition of controlling the thrombotic disease effect in advance, and it is with a kind of Chinese medicine composition in tea-drinking dietetic therapy mode, it is characterized in that the compound recipe of this Chinese medicine composition and proportioning are as follows:
Radix Glycyrrhizae 0.05~0.1g
Flos Chrysanthemi Indici 0.05~0.1g
Fructus Hordei Vulgaris 0.1~0.3g
The Radix Astragali 1~2g
Radix Salviae Miltiorrhizae 2~4g
Herb Gynostemmae Pentaphylli 1~2g
Folium Ginkgo 0.5~1.5g
Radix Et Rhizoma Rhei 0.1~0.5g
Fructus Crataegi 0.2~0.8g.
2, a kind of Chinese medicine composition of controlling the thrombotic disease effect in advance that has according to claim 1, it is characterized in that: the compound recipe of this Chinese medicine composition and proportioning are:
Radix Glycyrrhizae 0.05g
Flos Chrysanthemi Indici 0.05g
Fructus Hordei Vulgaris 0.1g
Radix Astragali 2.5g
Radix Salviae Miltiorrhizae 2g
Herb Gynostemmae Pentaphylli 1g
Folium Ginkgo 0.5g
Radix Et Rhizoma Rhei 0.1g
Fructus Crataegi 0.2g.
3, a kind of Chinese medicine composition of controlling the thrombotic disease effect in advance that has according to claim 1 is characterized in that the compound recipe of this Chinese medicine composition and proportioning are:
Radix Glycyrrhizae 0.1g
Flos Chrysanthemi Indici 0.1g
Fructus Hordei Vulgaris 0.2g
Radix Astragali 2g
Radix Salviae Miltiorrhizae 1.3g
Herb Gynostemmae Pentaphylli 1.4g
Folium Ginkgo 0.8g
Radix Et Rhizoma Rhei 0.3g
Fructus Crataegi 0.3g.
4, a kind of Chinese medicine composition of controlling the thrombotic disease effect in advance that has according to claim 1 is characterized in that the compound recipe of this Chinese medicine composition and proportioning are:
Radix Glycyrrhizae 0.1g
Flos Chrysanthemi Indici 0.1g
Fructus Hordei Vulgaris 0.1g
Radix Astragali 3g
Radix Salviae Miltiorrhizae 1g
Herb Gynostemmae Pentaphylli 1g
Folium Ginkgo 1g
Radix Et Rhizoma Rhei 0.1g
Fructus Crataegi 0.1g.
5, have the Chinese medicine composition of controlling the thrombotic disease effect in advance according to claim 1 or 2 or 3 or 4 a kind of, it is characterized in that in the compound recipe of this Chinese medicine composition that it is 40~80 orders that used Chinese herbal medicine is pulverized the back fineness.
6, any one of claim 1-5 has the preparation method of the Chinese medicine composition of controlling the thrombotic disease effect in advance, each Chinese herbal medicine is carried out selection, cleaning, drying, compatibility, pulverizes, is packaged into product, it is characterized in that Radix Astragali selection is a Radix Astragali, the place of production in Heilungkiang, Shan is sweet peaceful, clean the back Radix Astragali is adopted processed with honey technology, become Radix Astragali (processed with Mel), last compatibility and pulverizing.
CNB011267186A 2001-09-11 2001-09-11 Baoling tea for preventing and treating thrombosis and its preparing process Expired - Fee Related CN1150025C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011267186A CN1150025C (en) 2001-09-11 2001-09-11 Baoling tea for preventing and treating thrombosis and its preparing process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011267186A CN1150025C (en) 2001-09-11 2001-09-11 Baoling tea for preventing and treating thrombosis and its preparing process

Publications (2)

Publication Number Publication Date
CN1338283A CN1338283A (en) 2002-03-06
CN1150025C true CN1150025C (en) 2004-05-19

Family

ID=4666727

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011267186A Expired - Fee Related CN1150025C (en) 2001-09-11 2001-09-11 Baoling tea for preventing and treating thrombosis and its preparing process

Country Status (1)

Country Link
CN (1) CN1150025C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315519C (en) * 2004-12-23 2007-05-16 季友林 Blood fat regulating Chinese medicinal composition, its preparation and using method
CN100348224C (en) * 2005-05-08 2007-11-14 香港生物科技研究院有限公司 Chinese medicinal capsule used for reducing blood fat, its preparation method and use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101869679A (en) * 2010-06-11 2010-10-27 上海五邦医药科技有限公司 Traditional Chinese medicine preparation capsule for treating ischemic stroke

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315519C (en) * 2004-12-23 2007-05-16 季友林 Blood fat regulating Chinese medicinal composition, its preparation and using method
CN100348224C (en) * 2005-05-08 2007-11-14 香港生物科技研究院有限公司 Chinese medicinal capsule used for reducing blood fat, its preparation method and use

Also Published As

Publication number Publication date
CN1338283A (en) 2002-03-06

Similar Documents

Publication Publication Date Title
CN1224614A (en) Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation
CN1150025C (en) Baoling tea for preventing and treating thrombosis and its preparing process
CN1907401A (en) Decoction preparation for treating chronic eczema and its preparation process
CN101041018A (en) Chinese traditional medicine took orally for treating cold trigeminal neuralgia
CN1879823A (en) A medicinal liquor for treating kidney-yin deficiency type hematuria and method for preparing same
CN1879825A (en) A medicinal liquor for treating lower jiao heat accumulation type hematuria and method for preparing same
CN103463427B (en) Medicinal tea for treating arteriosclerosis
CN101301442B (en) Decoction for treating papulopustular type acne
CN100998666B (en) Oral traditional Chinese medicine for treating trifacial neuralgia of cold-condensing and blood-stasis type
CN101002865A (en) Oral traditional Chinese medicine for treating rheumatismal trifacial neuralgia
CN1720957A (en) Blood fat regulating Chinese medicinal composition, its preparation and using method
CN115554372B (en) Traditional Chinese medicine for treating primary fibromyalgia syndrome and preparation method and application thereof
CN102225119A (en) Medicine for treating headache and preparation method thereof
CN102048154A (en) Health protection food having function of regulating blood sugar and preparation method thereof
CN1958015A (en) Chinese traditional medicine to be taken orally for treating disease of asthma in cough type
CN105435018A (en) Traditional Chinese medicine preparation for treating gout and preparation method thereof
CN1772179A (en) Chinese herbal medicine decoction for treating wetness type low fever and its prepn
CN103947799A (en) Five-ingredient health tea
CN1915311A (en) Medication of medical broth for treating chronic cough, and preparation method
CN100998771A (en) Oral traditional Chinese medicine for treating trigeminal neuralgia of abundant expectoration type
CN1915338A (en) Medication of medical broth for treating wind-cold type chronic cough, and preparation method
CN1872149A (en) Medical broth for treating winter pruritus, and preparation method
CN1814060A (en) Chinese herbal medicine decoction for treating appendicitis-ache and preparing method
CN1872295A (en) Medication of medicinal broth for treating hyperlipemia in type of excessive rise of liver-yang
CN1257720A (en) Medicine for treating hypercoagulable blood and its preparing process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040519

Termination date: 20170911

CF01 Termination of patent right due to non-payment of annual fee